New frontiers in evaluation of impacts of medical research

International Workshop 2009

Both politicians and funders are now facing increasing demands for follow-up of investment in research. In May 2009, the Scientific Council for Medicine brought together representatives of universities, funders, decision-makers and evaluators to discuss development and challenges in the field concerning how to measure the benefit of investments in medical research.

There is great international interest in identifying better ways of measuring the benefit of investments in medical research. The documentation summarises the main features of the different lectures and suggestions on how research findings can be measured.

MORE WITHIN THE SAME SUBJECT AREA

  1. Madeleine Durbeej-Hjalt appointed Secretary General for Medicine and Health

    She is a professor of muscle biology and a great advocate for basic researcher-initiated research. But Madeleine Durbeej-Hjalt thinks that one of the most important tasks right now is to consider the ongoing pandemic and its consequences.

  2. Sweden participates in clinical WHO study

    Sweden is participating in a major clinical study conducted by WHO, aimed at testing a number of antiviral medicines on patients around the world who are being treated for COVID-19.